News
TRSBF
0.828
NaN%
--
Weekly Report: what happened at TRSBF last week (0421-0425)?
Weekly Report · 1d ago
Weekly Report: what happened at TRSBF last week (0414-0418)?
Weekly Report · 04/21 11:23
3SBio’s 707 Injection Receives Breakthrough Therapy Designation in China
TipRanks · 04/17 08:38
Weekly Report: what happened at TRSBF last week (0407-0411)?
Weekly Report · 04/14 11:12
Weekly Report: what happened at TRSBF last week (0331-0404)?
Weekly Report · 04/07 11:12
Weekly Report: what happened at TRSBF last week (0324-0328)?
Weekly Report · 03/31 11:23
3SBio’s Strong Financial Performance and Expanding Pipeline Justify Buy Rating
TipRanks · 03/27 11:57
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Acrivon Therapeutics, Inc. (ACRV) and 3SBio (OtherTRSBF)
TipRanks · 03/26 12:10
3SBio Announces Strong Financial Results for 2024
TipRanks · 03/25 22:07
3SBio Announces Final Dividend for 2024
TipRanks · 03/25 22:07
Weekly Report: what happened at TRSBF last week (0317-0321)?
Weekly Report · 03/24 11:11
Weekly Report: what happened at TRSBF last week (0310-0314)?
Weekly Report · 03/17 11:22
Weekly Report: what happened at TRSBF last week (0303-0307)?
Weekly Report · 03/10 11:24
Weekly Report: what happened at TRSBF last week (0224-0228)?
Weekly Report · 03/03 11:23
Weekly Report: what happened at TRSBF last week (0217-0221)?
Weekly Report · 02/24 11:22
Weekly Report: what happened at TRSBF last week (0210-0214)?
Weekly Report · 02/17 11:20
Weekly Report: what happened at TRSBF last week (0203-0207)?
Weekly Report · 02/10 11:14
Weekly Report: what happened at TRSBF last week (0127-0131)?
Weekly Report · 02/03 11:18
Weekly Report: what happened at TRSBF last week (0120-0124)?
Weekly Report · 01/27 11:22
Weekly Report: what happened at TRSBF last week (0113-0117)?
Weekly Report · 01/20 11:13
More
Webull provides a variety of real-time TRSBF stock news. You can receive the latest news about 3Sbio through multiple platforms. This information may help you make smarter investment decisions.
About TRSBF
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.